In Toronto last night, at a gala celebration at the Ripley’s Aquarium of Canada, Cantech Letter Editor Nick Waddell presented the 7th Annual Cantech Letter Awards to a crowd of several hundred tech enthusiasts.
The nominees included a mix of new and familiar names, including TIO Networks and its CEO Hamed Shahbazi. Though TIO was thwarted in its bid for a third consecutive TSXV Canadian Tech Stock of the Year Award, Shahbazi himself completed the hat-trick as TSXV Tech Executive of the Year.
The Cantech Letter Awards recognize excellence in Canada’s innovation sectors. They are selected by an anonymous panel of more than 40 sell-side analysts from dozens of Canadian investment banks.
Here is a complete list of nominees and finalists for the 2016 Cantech Letter Awards…
2016 CANTECH LETTER AWARDS FINALISTS
CANADIAN TECH STOCK OF THE YEAR (TSX)
• Intrinsyc Technologies Corp
• OpenText
• Shopify
Winner: Shopify
CANADIAN TECH STOCK EXECUTIVE OF THE YEAR (TSX)
• Mark Barrenechea, OpenText
• Tobias Lutke, Shopify
• Elliot Noss, Tucows
Winner: Mark Barrenechea, OpenText
CANADIAN TECH STOCK OF THE YEAR (TSXV)
• AcuityAds
• Symbility Solutions
• Tio Networks
Winner: AcuityAds
CANADIAN TECH STOCK EXECUTIVE OF THE YEAR (TSXV)
• Mike Checkley, QHR
• Tal Hayek, AcuityAds
• Hamed Shahbazi, TIO Networks
Winner: Hamed Shahbazi, TIO Networks
CANADIAN LIFE SCIENCES STOCK OF THE YEAR
• Knight Therapeutics
• Theratechnologies
• TSO3
Winner: Theratechnologies
Beacon analyst Kirk Wilson said Revolve Renewable Power (Revolve Renewable Power Stock Quote, Chart, News, Analysts, Financials TSXV:REVV) has taken an… [Read More]
In an April 2 report, Haywood analyst Neal Gilmer cut his target on Tilray Brands (Tilray Brands Stock Quote, Chart,… [Read More]
In an April 2 report, Roth Capital Markets analyst Scott Searle reiterated his “Buy” rating and $38.00 target on Aviat… [Read More]
Beacon Securities analyst Doug Cooper maintained his “Buy” rating on goeasy (goeasy Stock Quote, Chart, News, Analysts, Financials TSX:GSY) but… [Read More]
In an April 1 report, Roth Capital Markets analyst Scott Searle maintained his “Buy” rating and $180.00 target on Universal… [Read More]
In a March 31 report, Research Capital analyst Andre Uddin maintained his “Speculative Buy” rating and US$5.50 target on NervGen… [Read More]